At an event during the annual American Diabetes Association Scientific Sessions in San Francisco, representatives from PBM, health plan, drug manufacturing and patient advocacy groups came together to discuss the causes of increasing insulin prices and potential solutions to the problem.
IBM and the Juvenile Diabetes Research Fund are teaming up to pinpoint the factors that lead to the onset of type 1 diabetes in children.
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
The AHCA is back on the table, but not everyone is on board. Organizations like JDRF and even some House Republicans dissent, saying it increases burdens on those with pre-existing conditions.
Novo Nordisk has axed an experimental insulin pill from its pipeline citing commercial — not medical — reasons. It's the latest in a complex debate raging over the price of insulin and the cost of progress.
Bigfoot Biomedical is building an artificial pancreas, combining continuous glucose monitor tech with an insulin pump - and raising some capital to do so.